Unknown

Dataset Information

0

Monitoring Patient Response to Pembrolizumab With Peripheral Blood Exhaustion Marker Profiles.


ABSTRACT: Exhausted T cells are effector T cells that are silenced due to continuous T cell receptor (TCR) stimulation from persistent antigens. Characteristics of exhaustion include the increased expression of multiple inhibitory receptors such as programme death-1[PD-1], lymphocyte activation gene 3 [LAG-3], T cell Ig and mucin domain [TIM-3], the loss of effector cytokine secretion and altered transcriptional profile. The PD-1/PD-L1 interaction induces functional exhaustion of tumor-reactive cytotoxic T cells and interferes with anti-tumor T cell immunity. T cell exhaustion has been observed in metastatic melanoma patients where the exhaustion of tumor specific T cells suggests that tumor clearance has been impeded and contributed to tumor immune escape. Checkpoint immunotherapies are antibodies designed to block the interaction between the inhibitory receptors expressed on T cells and their respective ligands. Therapies such as anti-PD-1 (Pembrolizumab and Nivolumab) block these inhibitory receptors and are associated with a significant improvement in overall survival and progression free survival. However, only 20-40% of metastatic melanoma patients experience long-term benefit. In a cohort of 16 metastatic melanoma patients receiving pembrolizumab, blood was serially collected before each infusion (mean 8.3; range 1-12 cycles). The presence of inhibitory markers LAG-3, TIM-3, and PD-1 on the surface of T cells was examined and assessed in relation to patient response to identify if inhibitory markers can be used to differentiate responders from non-responders for Pembrolizumab. We confirmed that across a range of cycles (range 1-26) of pembrolizumab, PD-1 expression was significantly higher on CD4+ T cells from non-responders compared to responders and TIM-3 expressed on the surface of CD8+ T cells was significantly higher in non-responders compared to responders. This longitudinal data confirms previous studies that assessed single timepoints. This study provides preliminary evidence that PD-1 and TIM-3 may be predictive of non-responders when assessed over multiple treatment cycles.

SUBMITTER: Graves M 

PROVIDER: S-EPMC6540682 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Monitoring Patient Response to Pembrolizumab With Peripheral Blood Exhaustion Marker Profiles.

Graves Moira M   CelliMarchett Giovana G   van Zyl Belinda B   Tang Denise D   Vilain Ricardo E RE   van der Westhuizen Andre A   Bowden Nikola A NA  

Frontiers in medicine 20190522


Exhausted T cells are effector T cells that are silenced due to continuous T cell receptor (TCR) stimulation from persistent antigens. Characteristics of exhaustion include the increased expression of multiple inhibitory receptors such as programme death-1[PD-1], lymphocyte activation gene 3 [LAG-3], T cell Ig and mucin domain [TIM-3], the loss of effector cytokine secretion and altered transcriptional profile. The PD-1/PD-L1 interaction induces functional exhaustion of tumor-reactive cytotoxic  ...[more]

Similar Datasets

| S-EPMC5850489 | biostudies-literature
| S-EPMC4986384 | biostudies-literature
| S-EPMC8602893 | biostudies-literature
| S-EPMC5441116 | biostudies-literature
| S-EPMC4315702 | biostudies-literature
| S-ECPF-GEOD-24536 | biostudies-other
| S-EPMC7117874 | biostudies-literature
| S-ECPF-GEOD-15932 | biostudies-other
| S-EPMC3285188 | biostudies-literature
| S-EPMC1479811 | biostudies-other